[Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].
@article{Fujiki1997IfosfamideCI, title={[Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].}, author={T. Fujiki and K. Futatsuki and S. Akazawa and K. Yamamoto and Y. Kanda and A. Yamato and K. Terashi and Y. Suda}, journal={Gan to kagaku ryoho. Cancer & chemotherapy}, year={1997}, volume={24 5}, pages={ 569-72 } }
Ifosfamide chemotherapy was studied in 20 patients with advanced pancreatic carcinoma. It was administered at a dose of 1.2-1.5 g/body/day for 5 consecutive days every 3-4 weeks, and the patients treated over 2 courses were registered in our trial. Eleven patients had not received prior chemotherapy. Results achieved were as follows: PR in one patient, NC in 9 patients, and PD in 10 patients. The response rate was 5% and the median survival time was 17 weeks. Toxic effects included anorexia (80… CONTINUE READING
Topics from this paper
4 Citations
Novel treatments and therapies in development for pancreatic cancer
- Medicine
- Expert opinion on investigational drugs
- 2002
- 23
A multiprong approach to cancer gene therapy by coencapsulated cells
- Medicine
- Cancer Gene Therapy
- 2005
- 12
- PDF